Pharmacokinetic drug-drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management.

Pharmacokinetic drug-drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management.

Item
http://www.wikidata.org/entity/Q37414997
Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapySevere Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and Ticagrelor.Potassium induced contraction of the internal thoracic artery in vitro is time related: the potential consequences in the analysis of the mechanism of the spasm after coronary artery bypass grafting and in the analysis of the results of in vitro stuSevere rhabdomyolysis associated with simvastatin and role of ciprofloxacin and amlodipine coadministrationStatin drug-drug interactions in a Romanian community pharmacy.Lercanidipine in the Management of Hypertension: An Update.The Concomitant Use of Atorvastatin and Amlodipine Leading to Rhabdomyolysis.Onset timing of statin-induced musculoskeletal adverse events and concomitant drug-associated shift in onset timing of MAEs
P2860

Pharmacokinetic drug-drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management.

Item
http://www.wikidata.org/entity/Q37414997
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetic drug-drug inte ...... vant clinical risk management.
@en
Pharmacokinetic drug-drug inte ...... vant clinical risk management.
@nl
type
label
Pharmacokinetic drug-drug inte ...... vant clinical risk management.
@en
Pharmacokinetic drug-drug inte ...... vant clinical risk management.
@nl
prefLabel
Pharmacokinetic drug-drug inte ...... vant clinical risk management.
@en
Pharmacokinetic drug-drug inte ...... vant clinical risk management.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P698
P932
P356
P1433
P1476
Pharmacokinetic drug-drug inte ...... vant clinical risk management.
@en
P2093
P2860
P304
P31
P356
P478
P577
P698
P932